Modern Brachytherapy
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference123 articles.
1. A review of safety, quality management, and practice guidelines for high-dose-rate brachytherapy: executive summary;Thomadsen;Pract Radiat Oncol,2014
2. Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer;Kuban;Int J Radiat Oncol Biol Phys,2008
3. Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/american college of radiology 95-09;Zietman;J Clin Oncol,2010
4. Brachytherapy provides comparable outcomes and improved cost-effectiveness in the treatment of low/intermediate prostate cancer;Shah;Brachytherapy,2012
5. Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group;Grimm;BJU Int,2012
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Long-term outcomes of stereotactic ablative brachytherapy for recurrent aggressive fibromatosis: an eight-year retrospective multicenter study;2023-11-10
2. Monte Carlo characterization of the VariSource VS2000 HDR Iridium brachytherapy source;2023 3rd International Conference on Innovative Research in Applied Science, Engineering and Technology (IRASET);2023-05-18
3. Long-term oncological follow-up after mold-based pulsed dose rate brachytherapy for early stage squamous cell carcinoma of the nasal vestibule: A single center experience of 68 patients over a 17-year period;Brachytherapy;2023-03
4. Current radiotherapy for recurrent head and neck cancer in the modern era: a state-of-the-art review;Journal of Translational Medicine;2022-12-06
5. Surgically targeted radiation therapy (STaRT) trials for brain neoplasms: A comprehensive review;Neuro-Oncology;2022-11-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3